Premier's net income tumbled 92% in the fiscal 2018 second quarter ended Dec. 31, 2017 to $19.8 million, down from $246.2 million over the same period in the year prior, as the company endured a one-time adjustment of deferred taxes resulting from…Original Article
You may also like
The Great RIF(T): One FDA Division’s Destruction and...
More on the Impact of the FDA RIFs: How Information...
Court Rejects Challenge to DEA ALJ Hearing Authority...
Déjà Vu: OPDP Again Targets Provider Branded Website...
ASCA 2024 Performance Update: Can ASCA Improve...
Enforcement Under the New FDA: HPM to Host a Q&A...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.